Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

41.40 -1.73 (-4.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,231,631
Open 41.84
Bid (Size) 40.00 (1)
Ask (Size) 42.00 (2)
Prev. Close 43.13
Today's Range 41.05 - 42.94
52wk Range 11.81 - 44.92
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price
On Tuesday, the Cathie Wood-led Ark Invest made some significant trades. 
Via Benzinga

Performance

YTD
+19.52%
+19.52%
1 Month
+25.57%
+25.57%
3 Month
+11.98%
+11.98%
6 Month
+126.97%
+126.97%
1 Year
+208.96%
+208.96%

More News

Read More
Breaking Down Twist Bioscience: 5 Analysts Share Their Views
Via Benzinga
Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says
Via Benzinga
Analyst Scoreboard: 5 Ratings For Twist Bioscience
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
Via Benzinga
TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Via InvestorPlace
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Via Benzinga
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
Via Benzinga
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
Via Talk Markets
7 Stocks Cathie Wood Is Still Loading Up On in Q1
Via InvestorPlace
7 Sexy Stocks That Will Continue to Outperform in 2024
Via InvestorPlace
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
Via Benzinga
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
From Twist Bioscience Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.